Prospect Venture Partners - aVenture Asset Manager Research
Location
Palo Alto, CA, US
Founded
1997
Prospect Venture Partners is a venture capital firm managing over $1 billion in capital, focusing on biopharmaceutical and medical device companies. The firm invests across various stages, from seed to growth, targeting enterprises with proprietary products and innovative technologies. Their typical investment rounds include Series A, B, C, and beyond, supporting companies with diverse development and financing needs.
Notable portfolio companies include Amicus Therapeutics, Jazz Pharmaceuticals, NGM Biopharmaceuticals, and Element Science. The firm prides itself on partnering with exceptional entrepreneurial teams committed to excellence. Prospect Venture Partners offers unique value-add services, leveraging their extensive industry expertise to help portfolio companies achieve significant returns.
Prospect Venture Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
